BRIEFING

 Ioxaglate Meglumine and Ioxaglate Sodium Injection. This proposal is based on the version of the monograph official as of May 1, 2018. It is proposed to omit this monograph for the following reasons:

1. No drug products formulated as defined under Ioxaglate Meglumine and Ioxaglate Sodium Injection are currently marketed in the United States.

2. The drug product is currently not on the list for approved veterinary medicine in the United States.

 (SM4: S.Cusick)

 Case ID—SUB-3065